Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Ustekinumab yields sustained response in phase II and III trials in plaque psoriasis

Aug. 13, 2010

New models predict activity/selectivity of cannabinoid receptor agonists/antagonists

Aug. 11, 2010

Nabilone shows promise to treat cannabis use disorders

Aug. 10, 2010

Cannabidiol displays antiangiogenic activity in preclinical tests

Aug. 10, 2010

BPR-0912 exhibits antiobesity effects in vivo

Aug. 9, 2010

Preclinical study implicates GPR55 in regulation of osteoclast number and function

Aug. 6, 2010

Scientists explore neuroprotective role of URB-597 in models of retinal neurodegeneration

Aug. 6, 2010

PF-3845 has antiallodynic effects in preclinical study

Aug. 6, 2010

TM-38837 shows favorable safety and pharmacokinetics in healthy subjects

Aug. 5, 2010

Japanese scientists identify potential biomarkers for coronary artery disease

Aug. 5, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026